MedTrace Logo

64N Nutraceutical for the Prevention of Childhood Diarrhea and Pneumonia in Low Resource Settings

NCT02231047 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-11-18

No results posted yet for this study

Summary

The purpose of this study is to compare the occurrence of childhood diarrheal disease and pneumonia in subjects under the age of 5 years in low resource settings who have received prophylactic 64N nutraceutical (64N)as a neonate as compared with neonates who have not received prophylactic 64N.

Conditions

Interventions

DIETARY_SUPPLEMENT

64N Nutraceutical

40 mg/kg/day of powdered 64N mixed in 12 ounces of a warm drink for 1 week (7 days)

OTHER

No 64N Nutraceutical

12 ounce warm drink daily for 1 week (7 days)

Sponsors & Collaborators

  • H2O Health and Agriculture LLC

    lead OTHER

Principal Investigators

  • Donna M Rohrs, DHSc, PA · H2O Health and Agriculture LLC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Hours
Max Age
1 Day
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • Guatemala

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02231047 on ClinicalTrials.gov